Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Disposable scope could cut infection risk in ERCP

NCT ID NCT05225909

First seen Jan 24, 2026 · Last updated Jun 23, 2026 · Updated 32 times

Summary

This study tested a new single-use duodenoscope (aScope) in 59 patients at high risk of infection after ERCP, a procedure to treat bile duct problems. The goal was to see if the scope works well and to gather information on costs and complications. The results could help decide if single-use scopes are a good option to prevent infections from contaminated reusable scopes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Nottingham University Hospitals NHS Trust

    Nottingham, Nottingham, Ng7 2UH, United Kingdom

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

single-use duodenoscope (aScope)

What this could lead to

If successful, this could show that single-use scopes are a safe and effective option to reduce infection risk after ERCP.

What could go wrong

This is a small, observational study with only 59 participants, so results may not apply to all patients. It does not directly compare infection rates with reusable scopes.

Conditions

The condition(s) this trial relates to.

cholangitis Infections infectious disease primary sclerosing cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.